Research

rs2413450 — TMPRSS6 TMPRSS6 iron regulation variant

Intronic TMPRSS6 variant associated with lower MCV, MCH, and hemoglobin levels — adds locus-depth coverage of the TMPRSS6 iron-regulation axis beyond the primary Ala736Val missense variant

Strong Risk Factor Share

Details

Gene
TMPRSS6
Chromosome
22
Risk allele
T
Clinical
Risk Factor
Evidence
Strong

Population Frequency

CC
31%
CT
50%
TT
19%

See your personal result for TMPRSS6

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

TMPRSS6 rs2413450 — A Second Window on the Iron Gate

TMPRSS611 TMPRSS6
Transmembrane serine protease 6, also called matriptase-2 — a liver-expressed enzyme that negatively regulates iron absorption by cleaving hemojuvelin from the hepatocyte surface, thereby suppressing hepcidin production
sits at the centre of the body's iron-sensing machinery. Its most studied variant — Ala736Val (rs855791) — is the single strongest common genetic determinant of iron status. rs2413450 is a second, independent marker at the same locus: an intronic variant located approximately 426 nucleotides downstream of exon 14 in the TMPRSS6 transcript. It does not itself change the protein sequence, but its alleles tag functional variation in TMPRSS6 expression or splicing regulation, and it has been independently replicated in GWAS for red blood cell traits.

The Mechanism

Because rs2413450 is intronic, it does not directly alter the matriptase-2 protein. Instead, it acts as a regulatory tag variant22 regulatory tag variant
A non-coding variant in linkage disequilibrium with nearby functional variants, or one that directly affects intronic splicing enhancer/silencer sequences or gene expression levels
. The T allele at rs2413450 is associated with lower matriptase-2 activity, either through altered splicing efficiency or by tagging a haplotype that carries reduced-function regulatory elements. Less active matriptase-2 means less cleavage of hemojuvelin33 hemojuvelin
A co-receptor of BMP receptors on hepatocyte surfaces that amplifies BMP/SMAD signalling and thereby drives hepcidin transcription
, which in turn raises hepcidin. Higher hepcidin degrades ferroportin44 ferroportin
The only known iron exporter on the basolateral surface of duodenal enterocytes and macrophages — hepcidin binding triggers its internalization and degradation, blocking iron release into the bloodstream
on gut enterocytes, limiting iron entry into the circulation. The net result is the same as for the coding variant rs855791: smaller red blood cells (lower MCV), less hemoglobin per cell (lower MCH), and modestly reduced hemoglobin concentration.

The Evidence

The association was first reported in the landmark CHARGE Consortium GWAS55 CHARGE Consortium GWAS
Ganesh SK et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet, 2009
, which studied 24,167 Europeans and confirmed rs2413450 associated with MCV (P = 3 × 10⁻⁴¹), MCH (P = 9 × 10⁻³⁴), and hematocrit (P = 2 × 10⁻¹³) — effect sizes comparable to the primary TMPRSS6 missense variant.

A large trans-ethnic meta-analysis Chen et al.66 Chen et al.
Chen MH et al. Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global Populations. Cell, 2020
confirmed the T allele reduces MCH by 0.126 standard deviations (P = 5 × 10⁻¹⁶) across European, East Asian, African, South Asian, and Latino populations, establishing this as a robust multi-ethnic signal.

In African-ancestry cohorts77 African-ancestry cohorts
Gichohi-Wainaina WN et al. Associations between Common Variants in Iron-Related Genes with Haematological Traits in Populations of African Ancestry. PLoS One, 2016
, rs2413450 T carriers showed a 0.19 g/dL reduction in hemoglobin (P = 0.02), one of only four TMPRSS6 variants that successfully replicated European GWAS signals in African populations — suggesting the functional variant it tags is ancestrally shared rather than population-specific.

A Turkish case-control study Batar et al.88 Batar et al.
Batar B et al. The role of TMPRSS6 gene variants in iron-related hematological parameters in Turkish patients with iron deficiency anemia. Gene, 2018
found that rs2413450 was associated with elevated total iron-binding capacity in IDA patients — a marker of iron-starved erythropoiesis — consistent with the GWAS direction.

The evidence level is rated strong: the association has been replicated in multiple independent cohorts spanning diverse ancestries and total sample sizes exceeding 700,000 individuals. Effect sizes are modest (fractions of a standard deviation per allele) but robust.

Practical Implications

Carrying one or two copies of the T allele does not cause iron deficiency on its own. The effect is sub-clinical under conditions of adequate dietary iron. But when iron demand rises — during heavy menstrual cycles, pregnancy, vegetarian or vegan eating, endurance athletics, or blood donation — T carriers have a narrower margin before iron stores drop into deficiency range.

The most actionable step is knowing your ferritin level. Serum ferritin below 30 µg/L indicates depleted stores even when hemoglobin is still within range; below 12 µg/L is overt deficiency. If stores are adequate, standard dietary guidance applies. If stores trend low, dietary strategies to maximize absorption become important: pairing iron-rich foods with vitamin C, avoiding tea and coffee within an hour of iron-containing meals, and choosing iron bisglycinate99 iron bisglycinate
A chelated form absorbed via peptide transporters, partially bypassing hepcidin-controlled ferroportin, and better tolerated than ferrous sulfate in sensitive individuals
over ferrous sulfate if supplementing.

Interactions

This variant operates through the same hepcidin pathway as the primary TMPRSS6 missense variant rs855791. Carrying the T allele at rs2413450 in addition to the A allele at rs855791 may compound the iron-reducing effect, since both tag haplotypes with reduced matriptase-2 function — though the two variants are not in perfect linkage disequilibrium and capture partially overlapping and partially independent variance.

Interaction with HFE variants (rs1800562 C282Y, rs1799945 H63D) is the most clinically relevant context: HFE loss-of-function raises hepcidin sensitivity and causes iron overload, while TMPRSS6 T alleles raise hepcidin and limit absorption. In someone with borderline HFE heterozygosity, TMPRSS6 T alleles may actually attenuate iron accumulation. In someone with purely nutritional iron deficiency risk, no HFE context is needed — the TMPRSS6 effect stands alone.

Nutrient Interactions

iron increased_need

Genotype Interpretations

What each possible genotype means for this variant:

CC “Normal Iron Regulation” Normal

Protective C/C genotype — normal matriptase-2 activity

You carry two copies of the C allele at rs2413450. This is the more common genotype globally (about 31% of people), associated with normal matriptase-2 regulatory function, normal hepcidin suppression, and iron parameters in the expected population range. Your MCV, MCH, and hemoglobin are not reduced by this variant. Standard dietary iron intake is sufficient for most people with this genotype.

CT “One Risk Allele” Intermediate Caution

One T allele — modestly reduced iron parameters

The T allele at rs2413450 is associated in large GWAS with reductions in mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and hematocrit. The CHARGE Consortium study (24,167 Europeans; Ganesh et al. 2009, PMID 19862010) found some of the strongest genetic associations ever reported for these traits at this locus. As a heterozygote, you carry one copy of the regulatory haplotype that slightly impairs matriptase-2 function, leading to a marginal elevation in hepcidin and a correspondingly modest reduction in iron absorption efficiency. Ferritin is the most sensitive measure of iron stores; values below 30 µg/L indicate depleted stores even when hemoglobin appears normal.

TT “Two Risk Alleles” Reduced Warning

Two T alleles — reduced iron absorption efficiency

In the CHARGE Consortium GWAS (Ganesh et al. 2009, PMID 19862010), rs2413450 reached genome-wide significance for MCV (P = 3 × 10⁻⁴¹), MCH (P = 9 × 10⁻³⁴), and hematocrit (P = 2 × 10⁻¹³) — among the strongest iron-related genetic signals ever reported outside the primary coding variant rs855791. The trans-ethnic Cell study (Chen et al. 2020, n=746,667, PMID 32888493) confirmed the T allele lowers MCH by 0.126 SD, and a West African cohort study (Gichohi-Wainaina et al. 2016, PMID 27332551) replicated a 0.19 g/dL hemoglobin reduction in African-ancestry individuals. As a TT homozygote, you accumulate two additive doses of this hepcidin-elevating effect.

Serum ferritin is the key biomarker to track. Values below 30 µg/L indicate depleted stores even if hemoglobin appears within the laboratory reference range. Knowing your ferritin enables early intervention before frank anaemia develops.